Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Track income, expenses, savings, and debt payments to gain a clear view of your financial health and progress.
16,643 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
A new research note sets a bold 2027 price target for Procter & Gamble, arguing efficiency gains and steady demand co...
Three large-cap utilities have pulled back on rate-case concerns and regulatory overhangs. This report grades Edison ...
A major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...
Citi's latest research ties quantum risk to crypto governance, suggesting Ethereum could outperform Bitcoin as the et...
A week of policy chatter and market moves highlights a shift in China’s AI chip supply. While the president trump pus...
A clear, investor-friendly look at Iridex's Q1 2026 performance and what it could mean for the full year. Learn the n...
Rivian sits at a pivotal crossroads. This in-depth look weighs cash, partnerships, and a road map for growth to answe...
As AI-driven demand accelerates, the real trade sits with the equipment suppliers that power chip production. ASML, A...
Hyperliquid's new ETFs drew nearly $50 million in the first week, lifting the token price above $50 and signaling gro...
NVIDIA has stunned investors with a dramatic dividend move and a massive buyback. This article breaks down what it me...
Spot Bitcoin ETFs are dominating flows as institutions chase direct BTC exposure. This report compares leading funds ...